Figure 5.
Effect of troglitazone on caspases 3 (A) and 8 (B) in PLC/PRF/5 cells. PLC/PRF/5 cells were treated for 48 hours with 5 or 10 μM of troglitazone. The activity of caspase 3, but not that of caspase 8, was significantly increased in response to troglitazone in a dose dependent manner. **p<0.01.